Two-part joint model for a longitudinal semicontinuous marker and a terminal event with application to metastatic colorectal cancer data
{{output}}
Joint models for a longitudinal biomarker and a terminal event have gained interests for evaluating cancer clinical trials because the tumor evolution reflects directly the state of the disease. A biomarker characterizing the tumor size evolution over time can... ...
